HSChapter 30
U.S. exports of heparin and its salts; other human or animal substances (HS 300190) totaled $34.5M in July 2026.
Importers of Heparin and Its Salts; Other Human or Animal Substances paid $69K in duties in July 2026 — an effective duty rate of 10% on $692K in dutiable value, based on actual customs collections rather than the published tariff schedule. Heparin and Its Salts; Other Human or Animal Substances imports of $16.8M in July 2026 ran 12% below the year-to-date monthly average of $19.1M.
Last updated: July 2026 dataHeparin, an anticoagulant derived primarily from porcine intestinal mucosa, is one of the most clinically critical biological drug substances in global trade, and its supply chain drew intense regulatory scrutiny following the 2008 adulteration crisis. The US schedule subdivides the heading into dried liver and glands (3001900110, 3001900115, 3001900150), heparin and its salts (3001900165 and 3001900190), and other human or animal substances (3001900195). India and China are the leading suppliers, with Germany also a significant source; the concentration of porcine mucosa processing in China and India makes supply-chain traceability and FDA facility oversight a persistent compliance priority. Importers should consult a licensed customs broker and confirm FDA registration and cGMP status of the foreign establishment prior to entry.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
174 shipments/mo
FDA expects importers to maintain full traceability from the crude heparin source (typically porcine intestinal mucosa) through each processing step to the finished API. Required documentation typically includes certificates of analysis, supplier audit records, and evidence of FDA facility registration for each manufacturing site in the supply chain, consistent with FDA's heparin guidance issued after the 2008 adulteration incident.
The heading's 10-digit lines separate dried or powdered glandular material (3001900110, 3001900115, 3001900150) from heparin and its salts as discrete chemical entities (3001900165, 3001900190). The key distinction is whether the imported material is a processed, characterized drug substance (heparin) or a less-refined dried biological tissue; importers should ensure the certificate of analysis and product description clearly support the claimed line.
Subheading 1 of 2 in heading 3001
Subheading 300190 · $16.8M of $19.5M
Supplier Network
Get discovered by U.S. importers searching for HS 300190 — Heparin and Its Salts; Other Human or Animal Substances. Be the first supplier listed.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Dutiable Share | Duty Collected |
|---|---|---|---|---|---|
| 3001900195 | Other Human or Animal Substance, NESOI | $13.3M | 0.52% | 5.19% | $69K |
| 3001900165 | Heparin and Its Salts | $1.7M | 0.00% | 0.00% | -- |
| 3001900150 | Other Glands and Organs, Dried Etc | $1.3M | 0.00% | 0.00% | -- |
| 3001900110 | Liver, Dried, Whether or not Powdered | $424K | 0.00% | 0.00% | -- |
| 3001900190 | Heparin and Its Salts; Other Human or Animal Subst | $0 | -- | -- | -- |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3001900190 | Heparin and Its Salts; Other Human or Animal Subst | $33.4M |
| 3001900115 | Glands and Other Organs, Dried, Incl Powdered | $1.0M |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
ImportsExports
Imports
$16.8MYoY · Pro
Exports
$34.5MYoY · Pro
12-mo low · imports
YoY · ProThrough July 2026. Source: U.S. Census Bureau.
Exports · July 2026
destination
customs district
origin
entry
rate provision · imports
95.9% enters free of duty; the effective duty rate is 0.41%.